Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients

NCT02507492 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT02507492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02507492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2015
Completion date
July 31, 2018
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

homozygous or compound heterozygous pomc, lepr or pcsk1 gene mutation